GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Boiron SA (FRA:BON) » Definitions » Other Stockholders Equity

Boiron (FRA:BON) Other Stockholders Equity : €303.6 Mil (As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is Boiron Other Stockholders Equity?

Boiron's Other Stockholders Equity for the quarter that ended in Dec. 2023 was €303.6 Mil.

Boiron's quarterly Other Stockholders Equity increased from Dec. 2022 (€7.0 Mil) to Jun. 2023 (€460.9 Mil) but then declined from Jun. 2023 (€460.9 Mil) to Dec. 2023 (€303.6 Mil).

Boiron's annual Other Stockholders Equity increased from Dec. 2021 (€0.0 Mil) to Dec. 2022 (€7.0 Mil) and increased from Dec. 2022 (€7.0 Mil) to Dec. 2023 (€303.6 Mil).

Boiron Other Stockholders Equity Historical Data

The historical data trend for Boiron's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Boiron Other Stockholders Equity Chart

Boiron Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 6.97 303.63

Boiron Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 6.97 460.87 303.63

Boiron Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

Boiron Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Boiron's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Boiron (FRA:BON) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Boiron SA (FRA:BON) » Definitions » Other Stockholders Equity
Comparable Companies
XPAR:EAPI XPAR:AB XPAR:MLCOT XPAR:ALRPD XPAR:VETO ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XTAE:TEVA XSWX:SDZ VTRS SZSE:000538 NBIX HKSE:03692 TSE:4507 NSE:DIVISLAB BOM:500124 BOM:532321
Traded in Other Exchanges
BOIRF:USA BOI:France BON:Germany
Address
2, Avenue de l’Ouest Lyonnais No. 039, Messimy, FRA, 69510
Website
http://www.boiron.com
Boiron is a drug manufacturer that focuses on homeopathic products. The company's revenue is roughly split between its nonproprietary homeopathic medicines and products in its over-the-counter specialties category. Boiron's nonproprietary medicines are generic products that do not refer to any therapeutic indication, while the specialties category includes first-resort products provided in tablet form, are bottled to use as drops, syrups, or ointments. Geographical segments are France, Europe, North America, and other countries. It generates a majority of revenue from France. The company's products include Oscillococcinum, Stodal and Stodaline, Arnigel, Camilia, Sedatif PC, Coryzalia, Homeoptic, and Homeovox.